Emerging studies have shown that capsiate, a metabolite of the gut microbiota, upregulates GPX4 expression by activating transient receptor potential cation channel subfamily V member 1 (TRPV1), thereby inhibiting ferroptosis and protecting the intestine from ischemia/reperfusion injury [19]. The gene discussed is TRPV1; the disease is ischemia.